LAM-001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LAM-001, covering 2025-06-22 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. [Phase 2]